415 related articles for article (PubMed ID: 29775956)
1. Typology of new psychoactive substance use among the general Australian population.
Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
[TBL] [Abstract][Full Text] [Related]
2. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
3. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
4. Do police arrestees substitute legal highs for other drugs?
Wilkins C; Parker K; Prasad J; Jawalkar S
Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
[TBL] [Abstract][Full Text] [Related]
5. The rise of new psychoactive substance use in Australia.
Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
[TBL] [Abstract][Full Text] [Related]
6. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
Champion KE; Teesson M; Newton NC
Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
[TBL] [Abstract][Full Text] [Related]
7. Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.
Fernández-Calderón F; Cleland CM; Palamar JJ
Addict Behav; 2018 Mar; 78():85-93. PubMed ID: 29128711
[TBL] [Abstract][Full Text] [Related]
8. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
9. Polysubstance use, mental health and high-risk behaviours: Results from the 2012 Global Drug Survey.
Morley KI; Lynskey MT; Moran P; Borschmann R; Winstock AR
Drug Alcohol Rev; 2015 Jul; 34(4):427-37. PubMed ID: 25867685
[TBL] [Abstract][Full Text] [Related]
10. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
Matthews AJ; Bruno R; Dietze P; Butler K; Burns L
Drug Alcohol Depend; 2014 Nov; 144():218-24. PubMed ID: 25282306
[TBL] [Abstract][Full Text] [Related]
11. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substances: Purchasing and supply patterns in Australia.
Sutherland R; Bruno R; Peacock A; Dietze P; Breen C; Burns L; Barratt MJ
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28517235
[TBL] [Abstract][Full Text] [Related]
13. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
14. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
[TBL] [Abstract][Full Text] [Related]
15. The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years.
Chan G; Connor J; Hall W; Leung J
Addiction; 2020 Jan; 115(1):145-155. PubMed ID: 31357251
[TBL] [Abstract][Full Text] [Related]
16. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
[TBL] [Abstract][Full Text] [Related]
17. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
[TBL] [Abstract][Full Text] [Related]
18. Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
Elliott L; Haddock CK; Campos S; Benoit E
PLoS One; 2019; 14(12):e0225273. PubMed ID: 31794586
[TBL] [Abstract][Full Text] [Related]
19. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort.
Stefanis NC; Dragovic M; Power BD; Jablensky A; Castle D; Morgan VA
Schizophr Res; 2014 Jul; 156(2-3):211-6. PubMed ID: 24831390
[TBL] [Abstract][Full Text] [Related]
20. Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014.
Rácz J; Csák R; Tóth KT; Tóth E; Rozmán K; Gyarmathy VA
Drug Alcohol Depend; 2016 Jan; 158():154-8. PubMed ID: 26652897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
